FDA Warning Letter — Glenmark Pharmaceuticals Inc., USA

Case 58882 — FEI 3005658103

The FDA took a Warning Letter action against Glenmark Pharmaceuticals Inc., USA on Mar 30, 2009 (Elmwood Park, NJ). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action details

Facility
Glenmark Pharmaceuticals Inc., USA
Date
Mar 30, 2009
Fiscal Year
2009
Product Type
Drugs
Center
CDER
Location
Elmwood Park, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.